Pediatric Dermatology

Papers
(The TQCC of Pediatric Dermatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Acne and social media: A cross‐sectional study of content quality on TikTok72
Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents40
Disparities in telemedicine access for Spanish‐speaking patients during the COVID‐19 crisis35
Differences between pediatric and adult atopic dermatitis35
Successful management of an arteriovenous malformation with trametinib in a patient with capillary‐malformation arteriovenous malformation syndrome and cardiac compromise34
Epidermolysis bullosa pruriginosa treated with dupilumab32
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—A pooled analysis of trial data28
Psoriasiform dermatitis during dupilumab treatment for moderate‐to‐severe atopic dermatitis in children25
Vulvar aphthous ulcer after COVID‐19 vaccination25
Staphylococcal scalded skin syndrome: An epidemiological and clinical review of 84 cases24
Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database22
Pediatric teledermatology: A review of the literature19
Successful treatment of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome with tofacitinib19
Fractional CO2 laser‐assisted topical rifamycin drug delivery in the treatment of pediatric cutaneous leishmaniasis19
Henoch‐Schönlein purpura: Another COVID‐19 complication17
Tinea capitis: An update17
CARD14‐associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature17
Contrasting readability and availability of Spanish language with English language patient education materials16
Dupilumab for pediatric prurigo nodularis: A case report16
Head and neck dermatitis, a subtype of atopic dermatitis induced by Malassezia spp: Clinical aspects and treatment outcomes in adolescent and adult patients16
New‐onset head and neck dermatitis in adolescent patients after dupilumab therapy for atopic dermatitis15
“COVID toes”: A meta‐analysis of case and observational studies on clinical, histopathological, and laboratory findings15
Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS‐CoV‐2 and influenza A15
Predictors and age‐dependent pattern of psychologic problems in childhood atopic dermatitis15
Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders14
Poster Presentations14
Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research all14
Pediatric hematidrosis – A case report and review of the literature and pathogenesis14
Hair and skin predict cardiomyopathies: Carvajal and erythrokeratodermia cardiomyopathy syndromes13
Comparison of lichen sclerosus in boys and girls: A systematic literature review of epidemiology, symptoms, genetic background, risk factors, treatment, and prognosis13
Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: A retrospective analysis13
Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases13
Oral tofacitinib for the treatment of alopecia areata in pediatric patients13
Clinical features of recurrent Mycoplasma pneumoniae–induced rash and mucositis12
Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa12
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial12
Improving newborn skin health: Effects of diaper care regimens on skin pH and erythema12
Reactive infectious mucocutaneous eruption in children diagnosed with COVID‐1912
Linear porokeratosis with bone abnormalities treated with compounded topical 2% cholesterol/2% lovastatin ointment12
Long‐term sirolimus treatment in blue rubber bleb nevus syndrome: Case report and review of the literature12
Gianotti‐crosti syndrome in the setting of recent coronavirus disease‐19 infection12
Evaluation of electronic consults for outpatient pediatric patients with dermatologic complaints12
Biologics for pediatric psoriasis: A systematic review and meta‐analysis12
Teledermatology: How It Is Impacting the Underserved12
Dermatologic conditions in Down syndrome11
TH2 sensitization in the skin‐gut‐brain axis: How early‐life Th2‐mediated inflammation may negatively perpetuate developmental and psychologic abnormalities11
Infliximab therapy in an infant with Netherton syndrome11
The positive environmental impact of virtual isotretinoin management11
Clearance of atypical cutaneous manifestations of hyper‐IgE syndrome with dupilumab11
When is synchronous telehealth acceptable for pediatric dermatology?11
Nevus comedonicus syndrome: A systematic review of the literature11
Monkeypox disease in a breastfeeding infant11
Assessing vaccination reactions in pediatric patients with maculopapular cutaneous mastocytosis11
A systematic scoping review of racial, ethnic, and socioeconomic health disparities in pediatric dermatology10
Association between atopic dermatitis and headaches throughout childhood and adolescence—A longitudinal birth cohort study10
The anatomic distribution of isolated and syndrome‐associated port‐wine stain10
Primary hyperhidrosis in children: A review of therapeutics10
Experience using dupilumab for pediatric atopic dermatitis at a tertiary care c enter: Inadequate response and adverse events10
Vulvar vitiligo and lichen sclerosus in children: A clinical challenge10
Dermatologic considerations for transgender and gender diverse youth10
Patient‐reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross‐sectional survey9
Dermatofibrosarcoma protuberans (DFSP) in children: A combined multidisciplinary approach9
Is prolonged monitoring necessary? An updated approach to infantile hemangioma treatment with oral propranolol9
Papulo‐purpuric dermatitis of childhood: a distinct PLEVA‐like eruption associated to SARS‐CoV‐2 infection. Clinical, histopathological and immunohistochemical study of 10 cases9
Barriers to healthcare access in pediatric dermatology: A systematic review9
Psychosocial impact of epidermolysis bullosa on patients: A qualitative study9
Cutaneous body image: A window into the adolescent experience of dermatologic disease9
Toxic epidermal necrolysis and Stevens‐Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25‐year retrospective study at a single te9
Recurrent angioedema in childhood: hereditary angioedema or histaminergic angioedema?9
Paradoxical psoriasis in pediatric patients: A systematic review9
Photographic representation of skin tones in three dermatology journals9
“Accutane Check”: Insights into youth sentiment toward isotretinoin from a TikTok trend8
Epidermolysis bullosa simplex due to bi‐allelic DST mutations: Case series and review of the literature8
POSTER PRESENTATIONS8
Treatment practices in the management of scabies in infants younger than two months8
Geographic distribution and characteristics of the pediatric dermatology workforce in the United States8
Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy8
Efficacy of a lay community health worker (promotoras de salud) program to improve adherence to emollients in Spanish‐speaking Latin American pediatric patients in the United States 8
The natural history of laryngo‐onycho‐cutaneous syndrome: A case series of six pediatric patients and literature review8
Evaluation of emergency department utilization for dermatologic conditions in the pediatric population within the United States from 2009‐20158
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines8
Eosinophilic cellulitis in response to BNT162b2 COVID‐19 vaccination8
Chronic urticaria in children under 15 years of age: Clinical experience beyond the clinical trials8
Patch testing in skin of color: A brief report7
Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X‐linked (IPEX) syndrome7
Ichthyosis follicularis, atrichia and photophobia (IFAP) and hereditary mucoepithelial dysplasia: Two syndromes that share a common clinical spectrum7
Review of traction alopecia in the pediatric patient: Diagnosis, prevention, and management7
Diagnosing Omenn syndrome7
Acute urticaria preceding other COVID‐19–associated manifestations—A case report7
Transient abdominal telangiectasia of the newborn7
Demographic characteristics, clinical features, and optimal management of hospitalized patients with staphylococcal scalded skin syndrome7
Retrospective review of confluent and reticulated papillomatosis in pediatric patients7
BASCULE syndrome in a child with prior asymptomatic COVID‐19 infection7
Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate7
Atopic dermatitis and skin infections are a poorly documented crisis in Canada's Indigenous pediatric population: It's time to start the conversation7
Parent report of sleep health and attention regulation in a cross‐sectional study of infants and preschool‐aged children with atopic dermatitis7
7
Light‐based treatment of pediatric port‐wine birthmarks7
Skin and Mucosal Manifestations in NEMO Syndrome: A Case Series and Literature Review7
Does compliance to topical corticosteroid therapy reduce the risk of development of permanent vulvar structural abnormalities in pediatric vulvar lichen sclerosus? A retrospective cohort study7
Evaluation of neurodevelopmental symptoms in 10 cases of neonatal ichthyosis and sclerosing cholangitis syndrome7
Toxic epidermal necrolysis after first dose of Pfizer‐BioNTech (BNT162b2) vaccination with pharmacogenomic testing6
Language‐centered approach to care improvement in a pediatric dermatology clinic6
Genomic comparison of malignant melanoma and atypical Spitz tumor in the pediatric population6
Continuing patient care to underserved communities and medical education during the COVID‐19 pandemic through a teledermatology student‐run clinic6
Interventions to improve primary care provider management of atopic dermatitis: A systematic review6
Readability of online patient education materials for juvenile dermatomyositis6
A case of severe nivolumab‐induced lichen planus pemphigoides in a child with metastatic spitzoid melanoma6
Acral peeling as the sole skin manifestation of COVID‐19 in children6
Do clinical severity scores correlate with the quality of life in children with psoriasis? A cross‐sectional study of Iranian pediatric patients6
Adverse cutaneous effects of mitogen‐activated protein kinase inhibitors in children6
Hereditary fibrosing poikiloderma (POIKTMP syndrome) report of a new mutation and review of the literature6
A case of wild‐type rubella‐associated cutaneous granuloma in ataxia telangiectasia6
Treatment of pruritus with botulinum toxin in a pediatric patient with Fox‐Fordyce disease6
Parental atopy and risk of atopic dermatitis in the first two years of life in the BASELINE birth cohort study6
Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review6
Most common pediatric skin conditions managed in outpatient dermatology clinics in the United States stratified by race and ethnicity6
Manifestation of anxiety and depression among pediatric patients with psoriasis: A review6
Pediatric epidermolysis bullosa acquisita: A review6
Improving patient education for atopic dermatitis: A randomized controlled trial of a caregiver handbook6
Pediatric morphea state‐of‐the‐art literature review: Reframing morphea as a systemic disease6
Reactive infectious mucocutaneous eruption following COVID‐19 in an adolescent boy: Case report and review of the literature6
Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol6
Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin6
Intralesional steroid injections for inflammatory nail dystrophies in the pediatric population6
Management of acne in transgender and gender diverse youth Part 2: Unique considerations and strategies in medical treatment6
Disparities in telemedicine use during the COVID‐19 pandemic among pediatric dermatology patients6
Acute generalized exanthematous pustulosis in children and adolescents in Singapore: A ten‐year retrospective review6
Propranolol's effects on the sleep of infants with hemangiomas: A prospective pilot study6
Pediatric hidradenitis suppurativa: Describing care patterns in the emergency department6
Successful treatment of a 3‐year‐old girl with generalized pustular psoriasis using secukinumab monotherapy6
Hematohidrosis of the mid‐face and hands treated with oral oxybutynin6
Widespread cutaneous eruption after aluminum‐containing vaccination: A case report and review of current literature6
Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations5
Rapid response to secukinumab in a 5‐year‐old with deficiency of the interleukin‐36 receptor antagonist (DITRA) with severe scalp and nail involvement5
Heterogeneous cutaneous findings associated with intrauterine HSV infection: A case series and literature review5
Carpet beetle dermatitis mimicking bullous impetigo5
Skin concerns in patients with trisomy 21 (Down syndrome): A Mayo Clinic 22‐year retrospective review5
Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: A systematic review and meta‐analysis5
Catastrophic congenital hemangioma with severe coagulopathy leading to fatal cardiac failure: Case report and review5
Association between obesity and atopic dermatitis in children: A case‐control study in a high obesity prevalence population5
Review article: Emerging issues in pediatric skin of color, part 15
The scope of health insurance coverage of vitiligo treatments in the United States: Implications for health care outcomes and disparities in children of color5
Alopecia in children undergoing chemotherapy, radiation, and hematopoietic stem cell transplantation: Scoping review and approach to management5
That’s Not Molluscum! A literature review of 109 cases of subepidermal calcified nodules5
Steroid phobia on social media platforms5
Short anagen syndrome: A case series and algorithm for diagnosis5
Pruritus assessment tools for 6 to 7‐year‐old children: KidsItchyQoL and ItchyQuant5
Disseminated cutaneous tuberculosis from BCG vaccination site in an immunocompetent child5
Strategies to enhance pediatric clinical trial participation: A systematic review with narrative synthesis5
Review article: Emerging issues in pediatric skin of color, Part 25
A fatal case of malignant atrophic papulosis in a pediatric patient5
The spectrum of pediatric scarring alopecia: A retrospective review of 27 patients seen at Mayo Clinic5
Efficacy of procedural treatments for pediatric hidradenitis suppurativa: A systematic review5
Development of an artificial intelligence algorithm for the diagnosis of infantile hemangiomas5
Evolution of incidence of chilblain‐like lesions in children during the first year of COVID‐19 pandemic5
Low dose oral corticosteroids, microneedling, and topical 5‐fluorouracil: A novel treatment for recalcitrant pediatric vitiligo5
Hair at the intersection of dermatology and anthropology: A conversation on race and relationships5
Decreases in scabies and lice cases among the pediatric and adult populations during COVID‐195
Atopic dermatitis‐like graft‐versus‐host disease treated with dupilumab5
Cutaneous manifestations of obesity in Turkish children: A comparative study5
Epidermolysis bullosa with pyloric atresia associated with compound heterozygous ITGB4 pathogenic variants: Minimal skin involvement but severe mucocutaneous disease5
5
Photodocumentation in skin of color5
Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy5
A case of inflammatory linear verrucous epidermal nevus successfully treated with Brodalumab5
Commentary:Beta‐blockers and sleep problems5
Tumor necrosis factor‐alpha inhibitors and acne fulminans: Friend or foe?5
Tips for addressing common conditions affecting pediatric and adolescent patients with skin of color5
Tinea faciei caused by Trichophyton benhamiae in a child5
Management of tinea capitis in Israel: A comparative study5
Anogenital warts and relationship to child sexual abuse: Systematic review and meta‐analysis5
Skin of color images in pediatric dermatology textbooks5
Generalized infantile myofibromatosis with visceral involvement presenting as diffuse hypopigmented macules at birth4
Skin necrosis in spinal muscular atrophy: Case report and review of the literature4
Reflectance confocal microscopy in pediatric dermatology: A state‐of‐the‐art review4
Systematic review of the prevalence of onychomycosis in children4
Commentary: Language barriers in medicine and the role of the pediatric dermatologist4
Inflammatory bowel disease presenting with pyodermatitis‐pyostomatitis vegetans in a pediatric patient: A case report and review of the literature4
Analysis of lesional color to differentiate infantile hemangiomas from port‐wine birthmarks in infants less than 3 months old: A pilot study4
Severe allergic contact dermatitis to two different continuous glucose monitoring devices in a patient with glycogen storage disease type 9b4
Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age4
“Transient pseudo‐lentigines sign” in burrowing bug pigmentation4
Report of a case of RAVEN, hair heterochromia and autism in the setting of FGFR2 mutation4
Evaluation of a paraffin‐based moisturizer compared to a ceramide‐based moisturizer in children with atopic dermatitis: A double‐blind, randomized controlled trial4
Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry4
Confluent and reticulated papillomatosis in pediatric patients at an urban tertiary care center4
Influence of gender and sexual identity on adolescent skin health4
Autoimmune progesterone dermatitis in the adolescent population4
4
Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series4
A case report of PHF6 mosaicism: Beyond the classic Börjeson‐Forssman‐Lehmann syndrome4
A case series of live attenuated vaccine administration in dupilumab‐treated children with atopic dermatitis4
Cutis marmorata telangiectatica congenita: Incidence of extracutaneous manifestations and a proposed clinical definition4
Neurocutaneous melanocytosis‐associated malignant melanoma presenting with peritoneal seeding4
Acquired epidermodysplasia verruciformis (AEV) in three children after cardiac transplantation: A case series and review of the literature4
Perinatal‐lethal Gaucher disease presenting with blueberry muffin lesions4
The effect of fatty acids, vitamins, and minerals on pediatric atopic dermatitis: A systematic review4
Staphylococcal scalded skin syndrome: Clinical features, ancillary testing, and patient management4
Diagnostic approach to tinea capitis with kerion: A retrospective study4
Congenital malalignment of the great toenail: Conservative and definitive treatment4
Drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms following nivolumab and ipilimumab in a pediatric patient with melanoma4
Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS‐C4
Rapid improvement of skin lesions in CHILD syndrome with topical 5% simvastatin ointment4
Pediatric pulse dose corticosteroid therapy dosing and administration in the treatment of alopecia areata: A review of literature4
A randomized, observer‐blind, vehicle‐control, multi‐center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%‐containing medical device in ped4
Treatment of scarring alopecia from trauma and surgical procedures in young patients using follicular unit hair transplantation4
Ectodermal dysplasia with congenital adermatoglyphia (Basan syndrome): Report of two cases presenting with extensive congenital milia4
Heck’s disease occurring after Epstein‐Barr virus‐associated smooth muscle tumors in an immunosuppressed child4
Topical corticosteroids for noninvasive treatment of pyogenic granulomas4
Successful use of telemedicine for evaluation of infantile hemangiomas during the early COVID‐19 pandemic: A cross‐sectional study4
Periorbital hypopigmentation and telangiectasias: Clues to diagnosing neonatal lupus in skin of color4
Cutaneous presentation of bullous multisystem inflammatory syndrome in a child: A diagnosis not to “MIS‐C4
Reducing anxiety and preventing trauma in pediatric epidermolysis bullosa4
Pediatric melanoma in the Hispanic population: An analysis of institutional and national data4
Triple‐combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate‐to‐severe acne in children and adolescents: Randomized phase 2 study4
The disease burden of pediatric patients with atopic dermatitis in Japan4
Atypical aplasia cutis in association with Xia Gibbs syndrome4
Epidemiologic features and risk of scarring in pediatric patients with kerion celsi4
A case of prolidase deficiency in a male patient4
Delayed diagnosis of holocarboxylase synthetase deficiency in three patients with prominent skin findings4
Access as equity: Addressing the distribution of the pediatric dermatology workforce4
Severe reactive infectious mucocutaneous eruption mimicking drug‐induced epidermal necrolysis triggered by norovirus4
Facial hemihypertrophy in a girl with sturge‐weber syndrome: Treatment with oral sirolimus4
Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A two‐year case series of patient‐reported outcomes4
Bowel‐associated dermatosis‐arthritis syndrome in a child with very early onset inflammatory bowel disease4
Switching biologics in children with psoriasis: Results from the BiPe cohort4
Symmetric blaschkoid pityriasis rosea in a child3
Clinical overlap of PHACE and LUMBAR syndromes3
Painful nodules on the abdomen of a teenage male3
Acquired cutis laxa type II (Marshall syndrome) in a 3‐month‐old boy3
Acute generalized exanthematous pustulosis due to Epstein‐Barr virus infection in a neonate3
Pediatric vulvar lichen sclerosus: Does it resolve or does it persist after menarche?3
Treatment utilization and drug survival of systemic medications among commercially insured children with psoriasis3
Generalized verrucosis in GATA2 deficiency successfully treated with systemic acitretin and trichloroacetic acid3
Frictional melanosis: A pediatric case series3
Cutaneous mastocytosis in a child with a de novo GNB1 mutation3
Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents3
Allergic contact dermatitis to chlorhexidine‐containing antiseptics and their excipients in children: A series of six cases3
Perspectives and knowledge of acne vulgaris among young adolescents3
Topical corticosteroid phobia in adolescents with eczema and caregivers of children and adolescents with eczema: A cross‐sectional survey3
Cutaneous lesions and mitochondrial hearing loss: A case report3
A novel pathogenic RHOA variant in a patient with patterned cutaneous hypopigmentation associated with extracutaneous findings3
THE demographics and trends in pediatric melanoma in the United States: An analysis of the National Cancer Database3
Exogenous acral pigmentation secondary to beetle exposure3
KRIT1‐positive hyperkeratotic cutaneous capillary venous malformation3
Efficacy of pediatric dermatology Extension for Community Healthcare Outcomes (ECHO) sessions on augmenting primary care providers' confidence and abilities3
Erythema multiforme‐like eruption associated with plant‐induced allergic contact dermatitis in a pediatric patient: A case report3
Eruptive nevi in a patient with constitutional mismatch repair deficiency (CMMRD)3
Incorporating joint pain screening into the pediatric dermatologic examination3
0.043281078338623